Antagonist of growth hormone-releasing hormone induces apoptosis in LNCaP human prostate cancer cells through a Ca2+-dependent pathway.
about
Growth hormone-releasing hormone promotes survival of cardiac myocytes in vitro and protects against ischaemia-reperfusion injury in rat heartThe natural compound Guttiferone F sensitizes prostate cancer to starvation induced apoptosis via calcium and JNK elevationStimulation of proliferation of MCF-7 breast cancer cells by a transfected splice variant of growth hormone-releasing hormone receptor.Antioxidant activity of growth hormone-releasing hormone antagonists in LNCaP human prostate cancer line.Isoflurane-induced caspase-3 activation is dependent on cytosolic calcium and can be attenuated by memantine.Preclinical efficacy of growth hormone-releasing hormone antagonists for androgen-dependent and castration-resistant human prostate cancer.Paclitaxel induces apoptosis in breast cancer cells through different calcium--regulating mechanisms depending on external calcium conditions.New agonist- and antagonist-based treatment approaches for advanced prostate cancer.Agonistic analogs of growth hormone releasing hormone (GHRH) promote wound healing by stimulating the proliferation and survival of human dermal fibroblasts through ERK and AKT pathwaysGrowth hormone-releasing hormone antagonists abolish the transactivation of human epidermal growth factor receptors in advanced prostate cancer models.Inhibitory effects of antagonists of growth hormone-releasing hormone on growth and invasiveness of PC3 human prostate cancer.Inhibitory effects of antagonists of growth hormone releasing hormone on experimental prostate cancers are associated with upregulation of wild-type p53 and decrease in p21 and mutant p53 proteins.Antioxidant status and selected biochemical parameters of porcine ovarian granulosa cells exposed to lead in vitro.Magnetoelectric nanoparticles for delivery of antitumor peptides into glioblastoma cells by magnetic fields.
P2860
Q28576178-4866DAFF-058F-4616-B2D3-F7A631F66CDCQ35382090-9128FD33-13D4-453D-92AF-FE9105F56569Q35720666-0B619B9F-C3F1-4A76-AACE-23A65BD9E301Q37068539-C840F4E2-0516-48A8-8036-AC4143E6C49FQ37352382-D97A2FE5-2C99-4423-9335-0ED8A9A2D71BQ37519616-FD2A0A22-283D-4C03-B796-91B15630819BQ37645271-1FADB954-A6AC-4D5A-97A6-B7F9C4003674Q38042768-0B044EA8-52CD-4570-A3B3-713CFAE150F3Q38834106-FBDE7643-2B39-47F7-B90C-AFA7DAD1C04BQ38977467-E2E218AF-BE97-4934-949E-5D8A3FFE7691Q39317388-5DE862AE-37F7-41D0-AA0C-CDD82E558285Q39499342-496C44B1-7099-49DF-A2A9-C54BF7120C9AQ43150295-CF0DBA9A-7846-4D4D-801A-FB921F746FB1Q47652837-231080D1-6D1C-4722-959A-62093DE8386B
P2860
Antagonist of growth hormone-releasing hormone induces apoptosis in LNCaP human prostate cancer cells through a Ca2+-dependent pathway.
description
2005 nî lūn-bûn
@nan
2005 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Antagonist of growth hormone-r ...... ough a Ca2+-dependent pathway.
@ast
Antagonist of growth hormone-r ...... ough a Ca2+-dependent pathway.
@en
type
label
Antagonist of growth hormone-r ...... ough a Ca2+-dependent pathway.
@ast
Antagonist of growth hormone-r ...... ough a Ca2+-dependent pathway.
@en
prefLabel
Antagonist of growth hormone-r ...... ough a Ca2+-dependent pathway.
@ast
Antagonist of growth hormone-r ...... ough a Ca2+-dependent pathway.
@en
P2093
P2860
P356
P1476
Antagonist of growth hormone-r ...... rough a Ca2+-dependent pathway
@en
P2093
Ferenc Boldizsar
Jozsef L Varga
Marta Zarandi
Peter Nemeth
Reka A Horvath
Timea Berki
Zoltan Rekasi
P2860
P304
P356
10.1073/PNAS.0410006102
P407
P577
2005-02-22T00:00:00Z